The global oncology therapeutic drug monitoring market size was valued at USD 426.7 million in 2021 and is expected to reach a value of USD x million by 2028, growing at a CAGR of 5.8% during the forecast period 2022 to 2028.  It also includes market size and projection estimations for each of the five major regions from 2022 to 2028. The research report includes historical data, trending features, and market growth estimates for the future. Furthermore, the study includes a global and regional estimation and is further split by nations and categories within each region. The research also includes factors and barriers to the oncology therapeutic drug monitoring market growth, as well as their impact on the market's future growth. The report gives a comprehensive overview of both primary and secondary data. 

View Detailed Report Description Here -

The global oncology therapeutic drug monitoring market segmentation:
1) By Drug Class Type: 5-Fluorouracil, Docetaxel, Methotrexate, Paclitaxel, Imatinib
2) By cancer type: Lung Cancer, Prostate Cancer, Breast Cancer, Cervical Cancer, Gastric Cancer, Colorectal Cancer, Liver Cancer, Blood Cancer, Others.

The market has been growing due to the rising demand for monoclonal antibodies (mABs) as a result of the COVID-19 pandemic. The Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for three monoclonal antibodies intended for outpatient treatment of symptomatic COVID-19 patients in response to the high transmission and significant fatality rates.

Request sample report at

North American market is expected to witness the highest market share during the forecast period due to the well-established healthcare infrastructure. Furthermore, over the projected period, increased government support for cancer research and technology development is expected to stimulate the development of therapeutic proteins. Other major factors assisting the expansion of the industry are government assistance for infection control and management, the rising incidence of lifestyle-related disorders, and the growing population.

The oncology therapeutic drug monitoring market key players are Abbott (US), Thermo Fisher Scientific (US), Hoffmann-La Roche Ltd. (Switzerland), Siemens Healthineers AG (Germany), Danaher Corporation (US), Bio-Rad Laboratories (US), bioMérieux SA (France), Theradiag SA (France).

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: | D U N S® Number: 852781747